CorMedix Inc. (CRMD:NASDAQ) closed at $5.32 on November 6, 2026, up 1.72% on the day. The stock trades 59.1% below its 52-week high of $13.02 and 4.3% above its 52-week low of $5.10. Over the past year, it lost 50.6%. CorMedix Inc. is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, CRMD closed higher on 129 days (51%). Its best day was August 13, 2026 (+14.65%) and its worst was January 8, 2026 (-32.77%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.
Cormedix Inc is a biopharmaceutical company which focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical need.
Find more stocks like CRMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.